This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07192/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07192/identifier/pubchem-compound/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n5http://linked.opendata.cz/resource/drugbank/drug/DB07192/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07192/identifier/drugbank/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB07192/identifier/chemspider/

Statements

Subject Item
n2:DB07192
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n9:DB07192 n11:DB07192
dcterms:title
(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE
adms:identifier
n4:1116191 n5:99443663 n12:DB07192 n13:665 n14:950568
n6:IUPAC-Name
n7:271B5307-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B530D-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B530C-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B5309-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B530A-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B530B-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B5305-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B5303-363D-11E5-9242-09173F13E4C5 n7:271B5306-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B5304-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B5313-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B5314-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B530E-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B530F-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B5311-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B5310-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B5312-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B5319-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B531B-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B531C-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B5318-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B5317-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B531A-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B5308-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B5315-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B5316-363D-11E5-9242-09173F13E4C5